{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:23:16Z","timestamp":1791080596227,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T00:00:00Z","timestamp":1371513600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/bjc.2013.299","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T20:02:19Z","timestamp":1371585739000},"page":"493-496","source":"Crossref","is-referenced-by-count":92,"title":["Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11"],"prefix":"10.1038","volume":"109","author":[{"name":"Rotterdam Ocular Melanoma Study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A E","family":"Koopmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Vaarwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Paridaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N C","family":"Naus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"de Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,18]]},"reference":[{"key":"BFbjc2013299_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.exer.2012.04.010","volume":"100","author":"MH Abdel-Rahman","year":"2012","unstructured":"Abdel-Rahman MH, Cebulla CM, Verma V, Christopher BN, Carson WE 3rd, Olencki T, Davidorf FH (2012) Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival. Exp Eye Res 100: 26\u201331.","journal-title":"Exp Eye Res"},{"key":"BFbjc2013299_CR2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/sj.bjc.6605226","volume":"101","author":"J Bauer","year":"2009","unstructured":"Bauer J, Kilic E, Vaarwater J, Bastian BC, Garbe C, de Klein A (2009) Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer 101: 813\u2013815.","journal-title":"Br J Cancer"},{"key":"BFbjc2013299_CR3","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1158\/1078-0432.CCR-11-3227","volume":"18","author":"JS Khalili","year":"2012","unstructured":"Khalili JS, Yu X, Wang J, Hayes BC, Davies MA, Lizee G, Esmaeli B, Woodman SE (2012) Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res 18: 4345\u20134355.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2013299_CR4","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1167\/iovs.04-1460","volume":"46","author":"E Kilic","year":"2005","unstructured":"Kilic E, Naus NC, van Gils W, Klaver CC, van Til ME, Verbiest MM, Stijnen T, Mooy CM, Paridaens D, Beverloo HB, Luyten GP, de Klein A (2005) Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci 46: 2253\u20132257.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFbjc2013299_CR5","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1167\/iovs.11-7398","volume":"52","author":"N Mitsiades","year":"2011","unstructured":"Mitsiades N, Chew SA, He B, Riechardt AI, Karadedou T, Kotoula V, Poulaki V (2011) Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy. Invest Ophthalmol Vis Sci 52: 7248\u20137255.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFbjc2013299_CR6","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.1167\/iovs.08-2145","volume":"49","author":"MD Onken","year":"2008","unstructured":"Onken MD, Worley LA, Long MD, Duan S, Council ML, Bowcock AM, Harbour JW (2008) Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci 49: 5230\u20135234.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFbjc2013299_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1755-148X.2009.00609.x","volume":"22","author":"CD Van Raamsdonk","year":"2009","unstructured":"Van Raamsdonk CD, Barsh GS, Wakamatsu K, Ito S (2009a) Independent regulation of hair and skin color by two G protein-coupled pathways. Pigment Cell Melanoma Res 22: 819\u2013826.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFbjc2013299_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature07586","volume":"457","author":"CD Van Raamsdonk","year":"2009","unstructured":"Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM, Simpson EM, Barsh GS, Bastian BC (2009b) Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457: 599\u2013602.","journal-title":"Nature"},{"key":"BFbjc2013299_CR9","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","volume":"363","author":"CD Van Raamsdonk","year":"2010","unstructured":"Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O\u2019Brien J, Bastian BC (2010) Mutations in GNA11 in uveal melanoma. N Engl J Med 363: 2191\u20132199.","journal-title":"N Engl J Med"},{"key":"BFbjc2013299_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-4598-11-22","volume":"11","author":"E von Euw","year":"2012","unstructured":"von Euw E, Atefi M, Attar N, Chu C, Zachariah S, Burgess BL, Mok S, Ng C, Wong DJ, Chmielowski B, Lichter DI, Koya RC, McCannel TA, Izmailova E, Ribas A (2012) Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines. Mol Cancer 11: 22.","journal-title":"Mol Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2013299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013299","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:15:11Z","timestamp":1684415711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2013299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,18]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFbjc2013299"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2013.299","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,18]]}}}